Welcome to Alverno Clinical Laboratories LLC Providing clinical laboratory services to hospitals and healthcare providers throughout the Midwest.

Alverno Clinical Laboratories, LLC offers to its healthcare providers the FDA approved BD Affirm Vaginitis DNA Probe Panel. This test provides clinicians with identification of three organisms from one single specimen with increased sensitivity and increased specimen stability. For information on this test and other services Alverno provides, please contact us at 800-937-5521.

Alverno Clinical Laboratories, LLC is proud to announce the opening of its newest Patient Service Centers!

Patients can now visit Alverno at 1431 N. Western Avenue, Suite 509, Chicago, IL 60622. Our friendly staff is ready to provide you excellent phlebotomy services with outstanding customer service.  For more information please call the Patient Service Center at 773-772-7029.

Our new Patient Service Center in Michigan City is open for business.  Visit us at the 400 North Medical Center at  8733 West 400 North any time Monday - Thursday from 8 am to 4 pm and Fridays from 8 am to 3 pm (closed for lunch from 12:30 - 1 pm). To learn more about the Michigan City Patient Service Center, please call 219-879-8781.

_______________________________________________________________________________

Alverno Clinical Laboratories currently offers to its healthcare providers a FDA approved 2009 Novel H1N1 Influenza A by PCR test and a combination PCR test for Influenza A, Influenza B, and RSV.

For up-to-date healthcare provider information regarding influenza, visit Illinois Department of Public Health, Indiana State Department of Health, or for recommendations for clinical use of Influenza Diagnostic tests visit the Centers for Disease Control and Prevention (CDC).

For helpful hints to keep you and your family safe from the flu, please visit www.flu.gov.
________________________________________________________________________________

Alverno Clinical Laboratories offers a wide variety of clinical testing, including Glomerular Basement Membrane Antibody, C. difficile, EBV Antibody, and Herpes Culture.

Earlier this year, Alverno implemented a new ANA Screening platform. The BioPlex 2200 chooses clinically relevant antigens that show the best results for clinical sensitivity and specificity for each assay.